Unknown

Dataset Information

0

Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.


ABSTRACT: There is growing evidence that activation of metabotropic glutamate receptor 4 (mGlu4) leads to anxiolytic- and antipsychotic-like efficacy in rodent models, yet its relevance to depression-like reactivity remains unclear. Here, we present the pharmacological evaluation of ADX88178 [5-methyl-N-(4-methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl)thiazol-2-amine], a novel potent, selective, and brain-penetrant positive allosteric modulator of the mGlu4 receptor in rodent models of anxiety, obsessive compulsive disorder (OCD), fear, depression, and psychosis. ADX88178 dose-dependently reduced the number of buried marbles in the marble burying test and increased open-arm exploration in the elevated plus maze (EPM) test, indicative of anxiolytic-like efficacy. Target specificity of the effect in the EPM test was confirmed using male and female mGlu4 receptor knockout mice. In mice, ADX88178 reduced the likelihood of conditioned freezing in the acquisition phase of the fear conditioning test, yet had no carryover effect in the expression phase. Also, ADX88178 dose-dependently reduced duration of immobility in the forced swim test, indicative of antidepressant-like efficacy. ADX88178 reduced DOI (2,5-dimethoxy-4-iodoamphetamine)-mediated head twitches (albeit with no dose-dependency), and MK-801 [(5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine]-induced locomotor hyperactivity in mice, but was inactive in the conditioned avoidance response test in rats. The compound showed good specificity as it had no effect on locomotor activity in mice and rats at efficacious doses. Thus, allosteric activation of mGlu4 receptors can be a promising new therapeutic approach for treatment of anxiety, OCD, fear-related disorders, and psychosis.

SUBMITTER: Kalinichev M 

PROVIDER: S-EPMC4152882 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders.

Kalinichev Mikhail M   Le Poul Emmanuel E   Boléa Christelle C   Girard Françoise F   Campo Brice B   Fonsi Massimiliano M   Royer-Urios Isabelle I   Browne Susan E SE   Uslaner Jason M JM   Davis Matthew J MJ   Raber Jacob J   Duvoisin Robert R   Bate Simon T ST   Reynolds Ian J IJ   Poli Sonia S   Celanire Sylvain S  

The Journal of pharmacology and experimental therapeutics 20140619 3


There is growing evidence that activation of metabotropic glutamate receptor 4 (mGlu4) leads to anxiolytic- and antipsychotic-like efficacy in rodent models, yet its relevance to depression-like reactivity remains unclear. Here, we present the pharmacological evaluation of ADX88178 [5-methyl-N-(4-methylpyrimidin-2-yl)-4-(1H-pyrazol-4-yl)thiazol-2-amine], a novel potent, selective, and brain-penetrant positive allosteric modulator of the mGlu4 receptor in rodent models of anxiety, obsessive compu  ...[more]

Similar Datasets

| S-EPMC3263969 | biostudies-literature
| S-EPMC5895880 | biostudies-literature
| S-EPMC4529372 | biostudies-literature
| S-EPMC2574552 | biostudies-literature
| S-EPMC60883 | biostudies-literature
| S-EPMC4690453 | biostudies-literature
| S-EPMC6420870 | biostudies-literature
| S-EPMC3608436 | biostudies-literature
| S-EPMC3991565 | biostudies-literature
| S-EPMC4988345 | biostudies-literature